MicroRNA-198 Inhibits Proliferation and Induces Apoptosis of Lung Cancer Cells Via Targeting FGFR1
Author:
Affiliation:
1. Thoracic Department; Shanghai Chest Hospital Affiliated to Shanghai JiaoTong University; Shanghai 200030 China
2. Pulmonary Department; Shanghai Chest Hospital affiliated to Shanghai JiaoTong University; Shanghai 200030 China
Publisher
Wiley
Subject
Cell Biology,Molecular Biology,Biochemistry
Reference28 articles.
1. Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition;Acevedo;Cancer Cell,2007
2. DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: Implications for outcomes and histologic classification;Díaz-García;Carcinogenesis,2013
3. MicroRNA sponges: Competitive inhibitors of small RNAs in mammalian cells;Ebert;Nat Methods,2007
4. Gene amplifications associated with the development of hormone-resistant prostate cancer;Edwards;Clin Cancer Res,2003
5. Control of mitogenic and motogenic pathways by miR-198, diminishing hepatoma cell growth and migration;Elfimova;Biochim Biophys Acta,2013
Cited by 52 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Retraction: ‘MicroRNA‐198 Inhibits Proliferation and Induces Apoptosis of Lung Cancer Cells Via Targeting FGFR1’;Journal of Cellular Biochemistry;2024-04-09
2. circNINL facilitates aerobic glycolysis, proliferation, invasion, and migration in lung cancer by sponging miR-3918 to mediate FGFR1 expression;European Journal of Medical Research;2024-01-20
3. FGFR and inhibitors;Fibroblast Growth Factors;2024
4. Exosomal miRNAs as a Promising Source of Biomarkers in Colorectal Cancer Progression;International Journal of Molecular Sciences;2022-04-27
5. Circ_0004015 silencing represses cisplatin chemoresistance and tumor progression by reducing KLF8 in a miR-198-dependent manner in non-small cell lung cancer;Genomics;2022-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3